Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study.
TSUBAME 研究显示,在类风湿性关节炎患者接受 certolizumab pegol 治疗 24 小时后,血清 TNFα 水平可预测治疗 12 周的疗效
期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-021-02547-2
Miyazaki Yusuke, Nakano Kazuhisa, Nakayamada Shingo, Kubo Satoshi, Iwata Shigeru, Hanami Kentaro, Fukuyo Shunsuke, Miyagawa Ippei, Yamaguchi Ayako, Kawabe Akio, Saito Kazuyoshi, Tanaka Yoshiya